Veeco Instruments Inc.NASDAQ: VECO

Veeco Reports Third Quarter 2026 Financial Results

· Issued by Veeco Instruments Inc. via GlobeNewswire

Summary by 6ix AI

Veeco Instruments Inc., a maker of semiconductor process equipment, reported revenue of $209.4 million for the third quarter ended September 30, 2026, compared with $165.9 million a year earlier, and net income under US standard accounting rules (GAAP) of $13.6 million, or $0.21 per diluted share, compared with $10.6 million, or $0.17.

Key details

  • Non-GAAP net income for the third quarter ended September 30, 2026 was $24.1 million, or $0.36 per diluted share, compared with $21.8 million, or $0.36, a year earlier. Non-GAAP figures exclude items such as share-based compensation, merger costs and amortization of acquired intangible assets.
  • Non-GAAP operating income for the third quarter ended September 30, 2026 was $25.2 million, compared with $23.1 million a year earlier.
  • For the fourth quarter of 2026, Veeco expects revenue of $230 million to $260 million, GAAP diluted earnings per share of $0.34 to $0.53 and non-GAAP diluted earnings per share of $0.50 to $0.70.
  • Veeco revised its fiscal year 2026 guidance: revenue is expected at $790 million to $820 million, GAAP diluted earnings per share at $0.72 to $0.92 and non-GAAP diluted earnings per share at $1.32 to $1.52.
  • A conference call on the results was scheduled for November 4, 2026 at 5:00pm ET.

What’s still pending

  • The fourth quarter and full year 2026 figures are company forecasts given as expected ranges, not results.

6ix AI wrote this summary from the release below and checked it against the release.

Third Quarter 2026 Highlights:

  • Revenue of $209.4 million, compared with $165.9 million in the same period last year
  • GAAP net income of $13.6 million, or $0.21 per diluted share, compared with $10.6 million, or $0.17 earnings per diluted share in the same period last year
  • Non-GAAP net income of $24.1 million, or $0.36 per diluted share, compared with $21.8 million, or $0.36 per diluted share in the same period last year

PLAINVIEW, N.Y., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (Nasdaq: VECO) today announced financial results for its third quarter ended September 30, 2026. Results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and are also reported adjusting for certain items (“Non-GAAP”). A reconciliation between GAAP and Non-GAAP operating results is provided at the end of this press release.  

U.S. Dollars in millions, except per share data
 
GAAP Results Q3 '26 Q3 '25
Revenue $209.4 $165.9
Net income $13.6 $10.6
Diluted earnings per share $0.21 $0.17
Non-GAAP Results Q3 '26 Q3 '25
Operating income $25.2 $23.1
Net income $24.1 $21.8
Diluted earnings per share $0.36 $0.36
 

“Veeco’s third-quarter performance reflects solid execution and significant opportunities across our business,” said Bill Miller, Ph.D., Veeco’s Chief Executive Officer. “AI infrastructure investment is accelerating technology transitions across leading-edge logic and memory, advanced packaging, and high-speed optical connectivity. This is driving unprecedented customer engagement and order activity across our differentiated portfolio. With greater visibility and strategic investments to expand our manufacturing capacity, we believe Veeco is well positioned to exceed one billion dollars in revenue for the full year 2027.”

Guidance and Outlook

The following guidance is provided for Veeco’s fourth quarter 2026:

  • Revenue is expected in the range of $230 million to $260 million
  • GAAP diluted earnings per share are expected in the range of $0.34 to $0.53
  • Non-GAAP diluted earnings per share are expected in the range of $0.50 to $0.70

The following revised guidance is provided for Veeco’s fiscal year 2026:

  • Revenue is expected in the range of $790 million to $820 million
  • GAAP diluted earnings per share are expected in the range of $0.72 to $0.92
  • Non-GAAP diluted earnings per share are expected in the range of $1.32 to $1.52

Conference Call Information

A conference call reviewing these results has been scheduled for today, November 4, 2026 starting at 5:00pm ET. To join the call, dial 1-877-407-8029 (toll-free) or 1-201-689-8029. Participants may also access a live webcast of the call by visiting the investor relations section of Veeco's website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website that evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.

About Veeco

Veeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our laser annealing, ion beam, metal organic chemical vapor deposition (MOCVD), single wafer etch & clean and lithography technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, Veeco holds leading technology positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com.

No Offer or Solicitation

This communication is not intended to and shall not constitute an offer to purchase or the solicitation of an offer to buy or sell any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Forward-looking Statements

This press release contains “forward-looking statements”, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, as amended, that are based on management’s expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements include, but are not limited to, those regarding anticipated growth and trends in our businesses and markets, including trends related to artificial intelligence and high-performance computing, industry outlooks and demand drivers, statements regarding the pending merger with Axcelis, the timing of shipments, deliveries and revenue recognition, statements regarding shipments currently being held by U.S. Customs, our investment and growth strategies, our development of new products and technologies, our business outlook for current and future periods, our ongoing transformation initiative and the effects thereof on our operations and financial results, the timing, completion and expected benefits of the proposed transaction and other statements that are not historical facts. These statements and their underlying assumptions are subject to risks and uncertainties and are not guarantees of future performance. Factors that could cause actual results to differ materially from those expressed or implied by such statements include, without limitation: the level of demand for our products; global economic and industry conditions; global trade issues, including the effects of foreign and domestic tariffs and the ongoing trade disputes between the U.S. and China, and changes in trade and export license policies; our dependency on third-party suppliers and outsourcing partners; the timing of customer orders; our ability to develop, deliver and support new products and technologies; our ability to expand our current markets, increase market share and develop new markets; the concentrated nature of our customer base; cybersecurity attacks and our ability to safeguard sensitive information and protect our intellectual property rights in key technologies; the effects of regional or global health epidemics; delays in or failure to complete the proposed transaction, whether due to an inability by either party to satisfy one or more conditions to closing, including an inability to obtain regulatory approval in China, the occurrence of events or changes in circumstances that give rise to the termination of the applicable merger agreement by either party, or otherwise; risks related to the pendency of the proposed transaction and its effect on our business, financial condition, results of operations, cash flows and stock price; our ability to achieve the objectives of operational and strategic initiatives and attract, motivate and retain key employees, including as a result of the proposed transaction; diversion of management time and attention from ordinary course business operations to the proposed transaction and other potential disruptions to our business relating thereto; the variability of results among products and end-markets, and our ability to accurately forecast future results, market conditions, and customer requirements; the impact of our indebtedness, including our convertible senior notes and our capped call transactions; and other risks and uncertainties described in our SEC filings on Forms 10-K, 10-Q and 8-K, and from time-to-time in our other SEC reports. All forward-looking statements speak only to management’s expectations, estimates, projections and assumptions as of the date of this press release. The Company does not undertake any obligation to update or publicly revise any forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.

-financial tables attached-

Veeco Contacts:  
Investor Relations: Alex Delacroix(516) 528-1020[email protected]
Media: Brenden Wright(410) 984-2610[email protected]
 
Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
(in thousands, except per share amounts)
(unaudited)
 
  Three months ended September 30,  Nine months ended September 30,
     2026    2025    2026
    2025
Net sales $209,384 $165,881 $561,206  $499,277 
Cost of sales  128,995  98,178  350,157   294,380 
Gross profit  80,389  67,703  211,049   204,897 
Operating expenses, net:            
Research and development  35,059  28,988  98,277   89,062 
Selling, general, and administrative  28,534  24,654  82,179   73,609 
Amortization of intangible assets  411  771  1,723   2,413 
Merger costs  2,260  2,609  5,736   2,609 
Other operating expense (income), net  26  127  (160)  132 
Total operating expenses, net  66,290  57,149  187,755   167,825 
Operating income  14,099  10,554  23,294   37,072 
Interest income (expense), net  1,785  1,321  4,131   3,062 
Other income (expense), net  —  —  —   (653)
Income before income taxes  15,884  11,875  27,425   39,481 
Income tax expense  2,249  1,279  2,257   5,205 
Net income $13,635 $10,596 $25,168  $34,276 
             
Income per common share:            
Basic $0.22 $0.18 $0.41  $0.58 
Diluted $0.21 $0.17 $0.39  $0.57 
             
Weighted average number of shares:            
Basic  61,109  60,077  60,889   58,993 
Diluted  66,154  60,950  65,207   60,436 
 
Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in thousands)
 
  September 30,  December 31,
     2026    2025
  (unaudited)   
Assets      
Current assets:      
Cash and cash equivalents $205,321 $163,466
Short-term investments  277,184  226,763
Accounts receivable, net  154,064  110,685
Contract assets  26,884  34,838
Inventories  308,265  275,298
Prepaid expenses and other current assets  43,875  34,286
Total current assets  1,015,593  845,336
Property, plant and equipment, net  116,163  108,646
Operating lease right-of-use assets  24,715  24,606
Intangible assets, net  3,973  5,696
Goodwill  214,964  214,964
Deferred income taxes  123,538  122,935
Other assets  6,714  3,612
Total assets $1,505,660 $1,325,795
       
Liabilities and stockholders’ equity      
Current liabilities:      
Accounts payable $68,474 $55,345
Accrued expenses and other current liabilities  60,628  45,503
Contract liabilities  132,351  74,161
Income taxes payable  1,041  3,048
Total current liabilities  262,494  178,057
Deferred income taxes  458  532
Long-term debt  226,835  226,009
Long-term operating lease liabilities  31,480  31,837
Other liabilities  60,471  3,852
Total liabilities  581,738  440,287
       
Total stockholders’ equity  923,922  885,508
Total liabilities and stockholders’ equity $1,505,660 $1,325,795
 

Note on Reconciliation Tables

The below tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with GAAP. These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

Reconciliation of GAAP to Non-GAAP Financial Data (Q3 2026)
(in thousands)
(unaudited)
 
     Non-GAAP Adjustments    
     Share-Based        
Three months ended September 30, 2026    GAAP    Compensation    Amortization    Other    Non-GAAP 
Net sales $209,384       $209,384 
Gross profit  80,389 1,411       81,800 
Gross margin  38.4%       39.1%
Operating expenses  66,290 (7,003) (411) (2,260)  56,616 
Operating income  14,099 8,414  411  2,260 ^ 25,184 
Net income  13,635 8,414  411  1,643 ^ 24,103 
 

^ - See table below for additional details.

Other Non-GAAP Adjustments (Q3 2026)
(in thousands)
(unaudited)
 
Three months ended September 30, 2026     
Merger related expenses$2,260 
Subtotal 2,260 
Non-cash interest expense 292 
Non-GAAP tax adjustment * (909)
Total Other$1,643 
 

* - The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

Net Income per Common Share (Q3 2026)
(in thousands, except per share amounts)
(unaudited)
 
  Three months ended September 30, 2026
  GAAP Non-GAAP
Numerator:      
Net income available to common shareholders $13,635 $24,103
       
Denominator:      
Basic weighted average shares outstanding  61,109  61,109
Effect of potentially dilutive share-based awards  1,756  1,756
Dilutive effect of 2029 Convertible Senior Notes  3,289  3,289
Diluted weighted average shares outstanding  66,154  66,154
       
Net income per common share:      
Basic $0.22 $0.39
Diluted $0.21 $0.36
 
Reconciliation of GAAP to Non-GAAP Financial Data (Q3 2025)
(in thousands)
(unaudited)
 
     Non-GAAP Adjustments    
     Share-based       
Three months ended September 30, 2025     GAAP    Compensation    Amortization    Other    Non-GAAP 
Net sales $165,881       $165,881 
Gross profit  67,703 1,771       69,474 
Gross margin  40.8%       41.9%
Operating expenses  57,149 (7,374) (771) (2,663)  46,341 
Operating income  10,554 9,145  771  2,663 ^ 23,133 
Net income  10,596 9,145  771  1,261 ^ 21,773 
 

^ - See table below for additional details.

Other Non-GAAP Adjustments (Q3 2025)
(in thousands)
(unaudited)
 
Three months ended September 30, 2025  
Merger related expenses 2,609 
Other$54 
Subtotal 2,663 
Non-cash interest expense 283 
Non-GAAP tax adjustment * (1,685)
Total Other$1,261 
 

* - The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

Net Income per Common Share (Q3 2025)
(in thousands, except per share amounts)
(unaudited)
 
  Three months ended September 30, 2025
  GAAP Non-GAAP
Numerator:      
Net income available to common shareholders $10,596 $21,773
       
Denominator:      
Basic weighted average shares outstanding  60,077  60,077
Effect of potentially dilutive share-based awards  873  873
Diluted weighted average shares outstanding  60,950  60,950
       
Net income per common share:      
Basic $0.18 $0.36
Diluted $0.17 $0.36
 

(1) - The non-GAAP incremental dilutive shares includes the impact of the Company’s capped call transaction issued concurrently with our 2027 Notes, and as such, an effective conversion price of $18.46 is used when determining incremental shares to add to the dilutive share count. The GAAP incremental dilutive shares does not include the impact of the Company’s capped call transaction, and as such, an effective conversion price of $13.98 is used when determining incremental shares to add to the dilutive share count.

Reconciliation of GAAP Net Income to Non-GAAP Operating Income (Q3 2026 and 2025)
(in thousands)
(unaudited)
 
     Three months ended     Three months ended
  September 30, 2026 September 30, 2025
GAAP Net income $13,635  $10,596 
Share-based compensation  8,414   9,145 
Amortization  411   771 
Merger related expenses  2,260   2,609 
Interest (income) expense, net  (1,785)  (1,321)
Other  —   54 
Income tax expense (benefit)  2,249   1,279 
Non-GAAP Operating income $25,184  $23,133 
 

Reconciliation of GAAP to Non-GAAP Financial Data (Q4 2026)
(in millions, except per share amounts)
(unaudited)

 
          Non-GAAP Adjustments        
Guidance for the three months ending         Share-based             
December 31, 2026 GAAP Compensation Amortization    Other     Non-GAAP
Net sales $230  - $260        $230  - $260 
Gross profit  97  -  114  2  — —   99  -  116 
Gross margin  42% -  44%        43% -  44%
Operating expenses  73  -  75  (8) — (1)  64  -  66 
Operating income  24  -  39  10    1   35  -  50 
Net income $23  - $36  10  — 1  $34  - $47 
                       
Income per diluted common share $0.34  - $0.53        $0.50  - $0.70 
 
Income per Diluted Common Share (Q4 2026)
(in millions, except per share amounts)
(unaudited)
 
Guidance for the three months ending December 31, 2026 GAAP Non-GAAP
Numerator:                
Net income available to common shareholders $23 - $36 $34 - $47
                 
Denominator:                
Basic weighted average shares outstanding  61 -  61  61 -  61
Effect of potentially dilutive share-based awards  2 -  2  2 -  2
Dilutive effect of 2029 Convertible Senior Notes  3 -  3  3 -  3
Diluted weighted average shares outstanding  66 -  66  66 -  66
                 
Net income per common share:                
Income per diluted common share $0.34 - $0.53 $0.50 - $0.70
 
Reconciliation of GAAP Net Income to Non-GAAP Operating Income (Q4 2026)
(in millions)
(unaudited)
 
Guidance for the three months ending December 31, 2026                 
GAAP Net income $23  - $36 
Share-based compensation  10  -  10 
Merger related expense  1  -  1 
Interest expense (income)  (2) -  (2)
Income tax expense  3  -  5 
Non-GAAP Operating income $35  - $50 
 

Note: Amounts may not calculate precisely due to rounding.

Reconciliation of GAAP to Non-GAAP Financial Data (FY 2026)
(in millions, except per share amounts)
(unaudited)
 
          Non-GAAP Adjustments        
Guidance for the year ending         Share-based             
December 31, 2026 GAAP Compensation Amortization    Other     Non-GAAP
Net sales $790  - $820        $790  - $820 
Gross profit  309  -  325  6  —  —   315  -  331 
Gross margin  39% -  40%        40% -  40%
Operating expenses  261  -  262  (30) (2) (7)  222  -  224 
Operating income  48  -  63  36  2  7   93  -  108 
Net income $48  - $62  36  2  2  $89  - $102 
                       
Income per diluted common share $0.72  - $0.92        $1.32  - $1.52 
 
Income per Diluted Common Share (FY 2026)
(in millions, except per share amounts)
(unaudited)
 
Guidance for the year ending December 31, 2026 GAAP Non-GAAP
Numerator:                
Net income available to common shareholders $48 - $62 $89 - $102
                 
Denominator:                
Basic weighted average shares outstanding  61 -  61  61 -  61
Effect of potentially dilutive share-based awards  2 -  2  2 -  2
Dilutive effect of 2029 Convertible Senior Notes  3 -  3  3 -  3
Diluted weighted average shares outstanding  66 -  66  66 -  66
                 
Net income per common share:                
Income per diluted common share $0.72 - $0.92 $1.32 - $1.52
 
Reconciliation of GAAP Net Income to Non-GAAP Operating Income (FY 2026)
(in millions)
(unaudited)
 
Guidance for the year ending December 31, 2026                 
GAAP Net income $48  - $62 
Share-based compensation  36  -  36 
Amortization  2  -  2 
Merger related expense  7  -  7 
Interest expense (income)  (6) -  (6)
Income tax expense  6  -  7 
Non-GAAP Operating income $93  - $108 
 

View original source (GlobeNewswire)Veeco Instruments Inc. on 6ix

In the deck

Story so far

Earlier from Veeco Instruments

All Veeco Instruments news releases